“…Altered nuclear scaling is associated with many cancers, and cytopathologists monitor graded increases in nuclear size for cancer diagnosis and prognosis (Zink et al, 2004;Chow et al, 2012;. Importantly, nuclear size increases in cancer are frequently independent of gross ploidy changes (Lindberg, 1992;Miyamoto et al, 1992;Sørensen et al, 1992;Wang et al, 1992;Dangou et al, 1993;van Velthoven et al, 1995;Sørensen, 1996;Dey, 2010), implicating potential cytoplasmic contributions to altered nuclear size (Goehring and Hyman, 2012). It is unknown whether changes in nuclear size contribute to carcinogenesis, and answering this question necessitates an understanding of the mechanisms responsible for regulating nuclear size.…”